| Pharmaceutical active ingredients: |
| Iodamide Meglumine |
| Available forms, composition and doses of Renovue: |
| Injectable; Injection; Iodamide Meglumine 24%Injectable; Injection; Iodamide Meglumine 65% |
| Renovue medical category: |
| Human:Contrast mediums |
| Indications and usages, anatomical therapeutic chemical and diseases classification codes: |
| V08AA03 - Iodamide |
| Pharmaceutical companies: manufacturers, researchers, developers, local distributors and suppliers: |
| Bristol-Myers SquibbBracco |
| Trade name |
Active ingredients |
Pharmaceutical company |
|
Reno-M | Diatrizoate Meglumine | Bristol-Myers Squibb |
| Reno-M-Dip | Diatrizoate Meglumine | Bristol-Myers Squibb |
| Renoquid | Sulfacytine | Bristol-Myers Squibb; Glenwood |
| Renovist | Diatrizoate Meglumine; Diatrizoate Sodium | Bristol-Myers Squibb; Bracco |
| Renovist II | Diatrizoate Meglumine; Diatrizoate Sodium | Bristol-Myers Squibb; Bracco |
| Resedorm Liquid | Aprobarbital; Butabarbital | Bristol-Myers Squibb |
| Resedorm Tablets | Aprobarbital; Butabarbital; Butetamate Citrate | Bristol-Myers Squibb |
| Reseril | Nefazodone Hydrochloride | Bristol-Myers Squibb |
| Respalor | Preparation for Enteral Nutrition Lactose-free | Bristol-Myers Squibb; Mead Johnson Nutritionals |
| Resteclin | Amphotericin B; Tetracycline Hydrochloride; Vitamin C (Sodium Ascorbate) | Bristol-Myers Squibb |